Is there a vaccine against RSV? After nearly 60 years, many potential candidates came at the same time

Published Date: 02 Mar 2023

You may not have heard of respiratory syncytial virus (RSV). However, it killed more than 100,000 people worldwide in 2019, making it the leading cause of death among children under the age of one.

Read Full News

Latest News

Novartis MS Pill Beats Older Drug in Trials, Boosts Pipeline Hopes

(Corrects paragraph 12 to say remi is approved to treat only one skin condition, not two)

Maternal HIV Treatment May Aid Child Viral Load Suppression

Children living with HIV whose mothers receive antiretroviral therapy or achieve viral load suppression are more likely to receive antiretroviral therapy themselves.

Teva's Immune Disorder Drug Meets Main Goal in Mid-stage Trial

Israeli drugmaker Teva Pharmaceutical Industries, said on Wednesday its experimental drug helped prevent gluten-related intestinal damage in ⁠adults with celiac disease,...

Controversial Drug Suspended Due to Trial Irregularities

MHRA suspends new use of avacopan after concluding pivotal trial data can no longer be trusted, despite real-world evidence of efficacy.

Lipid-Lowering Drugs Tied to Worse Venom Anaphylaxis

Patients receiving lipid-lowering medications face roughly double the odds of severe anaphylaxis after Hymenoptera stings compared with those not taking these medications.

Exclusive-US Refusals Of Crucial Newborn Vitamin Spike, Raising Risk Of Dangerous Bleeding

The percentage of parents and caregivers in the United States refusing a standard vitamin K shot for infants at birth has accelerated sharply this year, an exclusive data...

Todays Updates

‘Modest’ Differences in OAT Should Not Obscure Benefits

Methadone may be linked to a lower risk for death than buprenorphine-naloxone in the short term, but after an overdose, either opioid agonist therapy is better than none.

Talc Powder Not Linked to Lung Cancer in Women

A study of US women finds no connection between talc powder use and lung cancer, though subgroup findings leave questions open.

Todays Updates

‘Modest’ Differences in OAT Should Not Obscure Benefits

Methadone may be linked to a lower risk for death than buprenorphine-naloxone in the short term, but after an overdose, either opioid agonist therapy is better than none.

Talc Powder Not Linked to Lung Cancer in Women

A study of US women finds no connection between talc powder use and lung cancer, though subgroup findings leave questions open.

Latest News

(Corrects paragraph 12 to say remi is approved to treat only one skin condition, not two)

Children living with HIV whose mothers receive antiretroviral therapy or achieve viral load suppression are more likely to receive antiretroviral therapy themselves.

Israeli drugmaker Teva Pharmaceutical Industries, said on Wednesday its experimental drug helped prevent gluten-related intestinal damage in ⁠adults with celiac disease,...

MHRA suspends new use of avacopan after concluding pivotal trial data can no longer be trusted, despite real-world evidence of efficacy.

Patients receiving lipid-lowering medications face roughly double the odds of severe anaphylaxis after Hymenoptera stings compared with those not taking these medications.

The percentage of parents and caregivers in the United States refusing a standard vitamin K shot for infants at birth has accelerated sharply this year, an exclusive data...

News All Time

Alumis Eyes Late-stage Lupus Study Despite Trial Miss

Alumis said on Tuesday it plans to advance its experimental drug for a type of immunity-related condition in a ⁠smaller subset of patients, even after the treatment failed...

Pumecitinib Spray May Ease Seasonal Allergy Symptoms

A topical JAK inhibitor delivered as a nasal spray may ease nasal and eye symptoms in adults with moderate-to-severe seasonal allergic rhinitis.

BioNTech Halts MRNA Colorectal Cancer Vaccine Trial After Safety Review

(This Aug 28 story has been repeated with no changes to text.)

Rapid ART Boosts Early HIV Care Retention

Starting antiretroviral therapy immediately after HIV diagnosis appears to keep patients engaged in care during critical early months, though the advantage fades by 1 year.

Deep Dive: NSAIDs: Selectivity Isn't Destiny

Dr Steven Nissen's PRECISION trial upended assumptions about which NSAID is "safest." A look at 7 agents through a cardiovascular, GI, and renal lens.

Rezpegaldesleukin Shows Promise in Atopic Dermatitis

A novel interleukin-2 receptor agonist demonstrates significant skin clearance and itch reduction in adults with moderate-to-severe atopic dermatitis in a phase 2 trial.

Handheld Device Accurately Detects Cancer, HIV Without Lab

A fluorimeter the size of an AirPod case replicates gold-standard lab assays and can deliver portable diagnostic testing for Staph infection, HIV, cancer, and more.

Serum IL-6 Levels and 9 CV and Mortality Outcomes

An analysis of the association between blood IL-6 measures from 14 multiethnic, prospective cohorts with follow-up data on any of 9 prespecified outcomes.

Forced Birth Control in Greenland Violated Women's Rights but Didn't Constitute Genocide, Experts Find

A campaign of forced contraception in Greenland that ran primarily in the 1960s and 1970s violated women's human rights but did not meet the legal definition of genocide,...

Early Antivirals May Cut Child Flu Hospitalization Risk

Antiviral treatment started within 48 hours of symptom onset is linked to a reduced risk for hospitalization among pediatric patients with influenza.

AstraZeneca-Amgen Asthma Drug Succeeds in Late-stage Oesophagus Disease Trial

AstraZeneca said on Thursday its asthma drug Tezspire met the main goals of a late-stage trial in patients with a chronic inflammatory disorder ⁠of the oesophagus, offering...

Food Allergy or Intolerance? Key Clues for Clinicians

Food reactions are not always allergies. A Paris expert outlined how timing, symptoms, and testing help clinicians separate intolerance from true immune-mediated disease.

US FDA Approves Gilead's Once-daily Combination Pill for HIV Treatment

(This Aug 27 story has been republished, with no changes to text.)

Success After a Century Of Failures: Inside Moderna and Merck's Cancer Vaccine Breakthrough

Stephane Bancel, CEO of Moderna, was at a Lebanese restaurant celebrating a friend’s birthday late on August 13 when he got the call.

Does PIH Coexist With Skin Inflammation? Experts Weigh In

‘Visible hyperpigmentation may mask persistent erythema and should not be assumed to indicate resolved inflammation,’ according to the authors of a recently published commentary.

Atopic Dermatitis Linked to Lower Height in Children

Children with moderate-to-severe atopic dermatitis show lower heights and higher BMI, a study finds.

Recommended News For You

Adjuvant Tx May Boost Survival in Bilateral Breast Cancer

Atezolizumab + Cabozantinib Postpones mCRPC Progression.

Pharyngoesophageal junction cancer is not a good candidate for endoscopically assisted transoral surgery.

Routine breast cancer screening can bring better outcomes for patients

Immunotherapy-TACE Regimen Boosts PFS in Unresectable Liver Cancer

Drug-chemo combo increases cancer treatment efficacy

The Boom in ADHD Coaching Has Few Rules

Recommended Articles For You

Quality of Life Optimization in Long-Term Cancer Survivorship 

Quality of Life Following Functional Restoration of Bone Marrow Reserve 

Advancing Cancer Trials: Integrating Master Protocols and Immunotherapy Guidelines 

Environmental Carcinogen Exposure Screening: Advances, Clinical Implications, and Guideline-Based Approaches 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Non-Hodgkin lymphomas that are indolent have been linked to psychological distress.

2.

FDA Approves Monthly Dosing of Rybrevant Faspro for NSCLC

3.

Invest in generics as a lesson from the shortages of chemotherapy.

4.

FDA Expands Use of T-DXd in Early HER2+ Breast Cancer

5.

Delaying Pegfilgrastim May Curb Bone Pain in Breast Cancer

1.

The Importance of Having a Quick and Effective Heparin Antidote 

2.

A Comprehensive Guide To Understanding Plasma Osmolality

3.

Machine Learning in Hematology: Boosting Diagnostic Precision and Speed in Medical Practice

4.

A New Hope: Exploring Treatment Options for Waldenstrom's Macroglobulinemia

5.

Beyond the Brain Fog: The Complex Neurological Challenges and Therapeutic Advances

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Navigating the Complexities of Ph Negative ALL - Part XI

2.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

3.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

4.

Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion

5.

Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot